These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32970450)

  • 1. Reply to Lipworth
    Moran AM; Ramakrishnan S; Borg CA; Connolly CM; Couillard S; Mwasuku CM; Pavord ID; Hinks TSC; Lehtimӓki L
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1743-1744. PubMed ID: 32970450
    [No Abstract]   [Full Text] [Related]  

  • 2. Don't Forget about Facilitatory Effects of Corticosteroids on β
    Lipworth B; Chan R; Kuo CR
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1743. PubMed ID: 32970458
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Lipworth
    Han YY; Forno E; Celedón JC
    Am J Respir Crit Care Med; 2020 Feb; 201(3):392-393. PubMed ID: 31639318
    [No Abstract]   [Full Text] [Related]  

  • 4. Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma.
    d'Ancona G; Kavanagh JE; Dhariwal J; Hearn AP; Roxas C; Fernandes M; Green L; Thomson L; Nanzer AM; Jackson DJ; Kent BD
    Allergy; 2021 Jul; 76(7):2238-2241. PubMed ID: 33432682
    [No Abstract]   [Full Text] [Related]  

  • 5. Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma.
    Pelaia G; Gallelli L; Romeo P; Renda T; Busceti MT; Proietto A; Grembiale RD; Marsico SA; Maselli R; Vatrella A
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):713-21. PubMed ID: 22122813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reslizumab: Maintenance treatment for eosinophilic asthma inadequately controlled on corticosteroids.
    Paton DM
    Drugs Today (Barc); 2016 Jun; 52(6):323-9. PubMed ID: 27458609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?
    Menzella F; Latorre M; Ruggiero P; Bagnasco D; Heffler E
    Expert Opin Biol Ther; 2019 Jul; 19(7):601-606. PubMed ID: 31033373
    [No Abstract]   [Full Text] [Related]  

  • 8. Exacerbation Rate Reduction With Mepolizumab Stratified by Maintenance Oral Corticosteroids Use and Eosinophil Levels: A Post Hoc Analysis of the DREAM and MENSA Studies.
    Bobolea I; Bañas D; Melero C; de Andrés AI; Joksaite S; Sánchez-Herrero G
    J Investig Allergol Clin Immunol; 2022 Apr; 32(2):148-150. PubMed ID: 34085935
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
    Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
    Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of reslizumab for patients with severe eosinophilic asthma inadequately controlled with high-dose inhaled corticosteroids and long-acting β
    Han S; Kim S; Kim H; Suh HS
    Curr Med Res Opin; 2019 Sep; 35(9):1597-1605. PubMed ID: 30964365
    [No Abstract]   [Full Text] [Related]  

  • 11. Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma.
    Meijer RJ; Postma DS; Kauffman HF; Arends LR; Koëter GH; Kerstjens HA
    Clin Exp Allergy; 2002 Jul; 32(7):1096-103. PubMed ID: 12100060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab for asthma in adults and children.
    Normansell R; Walker S; Milan SJ; Walters EH; Nair P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies.
    Goldman M; Hirsch I; Zangrilli JG; Newbold P; Xu X
    Curr Med Res Opin; 2017 Sep; 33(9):1605-1613. PubMed ID: 28644104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atopic dermatitis is an important comorbidity in severe asthma.
    Lee JK; Han D
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):661-662. PubMed ID: 29496463
    [No Abstract]   [Full Text] [Related]  

  • 15. Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.
    Chipps BE; Newbold P; Hirsch I; Trudo F; Goldman M
    Ann Allergy Asthma Immunol; 2018 May; 120(5):504-511.e4. PubMed ID: 29409951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Eosinophils, Fraction of Exhaled Nitric Oxide, and Serum Eosinophil Cationic Protein as Surrogate Markers for Sputum Eosinophils in Asthma: Influence of Treatment With Inhaled Corticosteroids.
    Alvarez Puebla MJ; Aroabarren Aleman E; Corcuera Garcia A; Ibañez Bereiz B; Iraola Iribar A; Olaguibel Rivera JM
    J Investig Allergol Clin Immunol; 2018 Jun; 28(3):210-212. PubMed ID: 29939147
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma: Effects Across a Broad Range of Eosinophil Counts.
    Corren J; Weinstein S; Janka L; Zangrilli J; Garin M
    Chest; 2016 Oct; 150(4):799-810. PubMed ID: 27018175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids in the treatment of severe acute asthma (status asthmaticus).
    Collins JV; Jones D
    Acta Tuberc Pneumol Belg; 1977; 68(1):63-73. PubMed ID: 930796
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
    Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of prednisolone on the cutaneous tuberculin response in patients with corticosteroid-resistant bronchial asthma.
    Sousa AR; Lane SJ; Atkinson BA; Poston RN; Lee TH
    J Allergy Clin Immunol; 1996 Feb; 97(2):698-706. PubMed ID: 8621857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.